TABLE 1.
Risk Group | Age (y) | Site | COG Stage | IGCCCG (if applicable) |
Predicted LTDF Survival (%) |
95%CI (%) | |
---|---|---|---|---|---|---|---|
LR |
0–15 0–16 Any |
Testicular Ovarian Extragonadal |
I I I |
|
100* 96* unknown** |
- 74–99 - |
|
SR1 |
<11 <11 <11 <11 <11 <11 |
Testicular Ovarian Testicular Ovarian Extragonadal Extragonadal |
II-III II-III IV IV II-III IV |
|
99 97 96 92 91 79 |
96–100 93–99 91–99 83–96 86–94 71–84 |
|
SR2 |
≥11 ≥11 ≥11 ≥11 |
Testicular Ovarian Testicular Extragonadal |
II-III II-III IV II |
Good |
93 85 83 65 |
84–97 77–91 67–91 48–78 |
|
PR |
≥11 ≥11 ≥11 ≥11 ≥11 |
Extragonadal Testicular Testicular Ovarian Extragonadal |
III II-IV II-IV IV IV |
Intermediate Poor |
65 75# 41# 67 40 |
48–78 71–79 35–47 49–80 24–56 |
Abbreviations: y, years; COG, Children’s Oncology Group; IGCCCG, International Germ Cell Cancer Collaborative Group;
MaGIC, Malignant Germ Cell International Consortium; LTDF, Long-term disease free survival; CI, Confidence Interval; LR, Low Risk; SR1, Standard Risk 1; SR2, Standard Risk 2; PR, Poor Risk
4 year Overall Survival used here
Currently being explored in COG AGCT 1531
5 year Event Free Survival used here
Bold Font: Risk Group, Age (y), Site, COG Stage, IGCCCG (if applicable), Predicted LTDF Survival (%), 95% CI (%)